REQUEST A DEMO
Total
USD $0.00
Search more companies

HBM Pharma s.r.o. (Slovakia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: HBM Pharma s.r.o. Profile Updated: March 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

HBM Pharma s.r.o. is an enterprise in Slovakia, with the main office in Martin. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. The enterprise was incorporated on March 02, 1992. 250 - 499 (2023) employees currently work for HBM Pharma s.r.o.. From the latest financial highlights, HBM Pharma s.r.o. reported a net sales revenue increase of 9.05% in 2021. Over the same period, its total assets grew by 7.45%. In 2021, HBM Pharma s.r.o.’s net profit margin increased by 4.19%.

Headquarters
Sklabinska 30
Martin; Zilinsky; Postal Code: 03680

Contact Details: Purchase the HBM Pharma s.r.o. report to view the information.

Website: http://www.hbmpharma.eu

Basic Information
Total Employees:
Purchase the HBM Pharma s.r.o. report to view the information.
Outstanding Shares:
Purchase the HBM Pharma s.r.o. report to view the information.
Registered Capital:
Purchase the HBM Pharma s.r.o. report to view the information.
Incorporation Date:
March 02, 1992
Key Executives
Purchase this report to view the information.
Member of the Board
Purchase this report to view the information.
Member of the Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after HBM Pharma s.r.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
9.05%
Total operating revenue
10.7%
Operating profit (EBIT)
83.16%
EBITDA
53.07%
Net Profit (Loss) for the Period
90.31%
Total assets
7.45%
Total equity
21.62%
Operating Profit Margin (ROS)
5.23%
Net Profit Margin
4.19%
Return on Equity (ROE)
6.42%
Debt to Equity Ratio
-26.18%
Quick Ratio
0.11%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?